QRGenetics is the developer of a powerful AI-supported drug discovery engine designed to identify potential therapies for common genetic diseases by uncovering new treatments for patients with similar rare-disease mutations.
From Genetic disease without treatment or unknown MOA to precision medicine for populations and address patent cliffs QRGenetics develop a powerful AI-supported drug discovery engine that utilizes exclusive spatial analytics and proprietary datasets, to rapidly discover novel drug-target combinations prompting new applications for soon-expired drugs.
QRGenetics’ drug discovery engine utilizes exclusive spatial analytics and proprietary omics datasets to rapidly produce novel drug and target combinations that are effective for multiple indications.